ACHE and early-onset autosomal dominant Alzheimer disease: The p(TA-co-LYS) nanogels have also shown high potential use as therapeutic agents to be used in the treatment of neurodegenerative diseases such as Alzheimer’s disease, due to their antioxidant and Fe(II) ion chelating capacity, as well as their AChE enzyme-inhibiting abilities.